Trousseau’s syndrome – what is the evidence?

David Bergqvist; Karin Wåhlander; Henry Eriksson; Nils H. Sternby; Mats Ögren

doi:10.1160/th05-10-0694

January 1, 2006Thrombosis and Haemostasis

Trousseau’s syndrome – what is the evidence?

View at Publisher

Ask AI

Bookmark

Share

Why the study?

Does the histological type, site, and spread of cancer independently affect the risk of pulmonary embolism?

Structured PICO

Does the histological type, site, and spread of cancer independently affect the risk of pulmonary embolism?

P

Population

23,796 standardised autopsies representing 84% of all in-hospital deaths in an urban Swedish population between 1970 and 1982.

I

Intervention

Presence of specific cancer types, sites, and growth patterns (e.g., pancreatic cancer, adenocarcinoma, metastatic cancer)

C

Comparator

Absence of cancer or different cancer types (e.g., squamous cell lung cancer)

O

Outcome

Prevalence of pulmonary embolism (PE) and fatal PEhard clinical

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

The risk of pulmonary embolism in cancer patients depends on the histological type, site, and spread, with pancreatic cancer and adenocarcinomas showing particularly high independent risks.

Abstract

No abstract yet. The journal hasn't published one we can show.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Bergqvist et al. (2006) studied this question.

synapsesocial.com/papers/6a70abdd78a11c550e0aa4a6 https://doi.org/10.1160/th05-10-0694

View at Publisher

Ask AI

Bookmark

Share

Trousseau’s syndrome – what is the evidence?

Structured PICO

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Trousseau’s syndrome – what is the evidence?

Structured PICO

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading